TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 47 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $671,000 | -63.1% | 5,984 | -61.6% | 0.02% | -56.0% |
| Q1 2017 | $1,819,000 | -53.5% | 15,600 | -58.1% | 0.05% | -63.0% |
| Q4 2016 | $3,916,000 | +24.2% | 37,200 | +69.1% | 0.14% | +46.7% |
| Q1 2016 | $3,152,000 | +6.8% | 22,000 | +15.2% | 0.09% | +24.3% |
| Q4 2015 | $2,952,000 | +22.2% | 19,100 | +13.0% | 0.07% | -19.6% |
| Q3 2015 | $2,415,000 | +47.4% | 16,900 | +48.2% | 0.09% | +119.0% |
| Q2 2015 | $1,638,000 | +16.8% | 11,400 | +14.0% | 0.04% | -34.4% |
| Q2 2014 | $1,402,000 | +26.3% | 10,000 | 0.0% | 0.06% | +10.3% |
| Q1 2014 | $1,110,000 | +331.9% | 10,000 | +284.6% | 0.06% | +222.2% |
| Q4 2013 | $257,000 | -6.2% | 2,600 | -27.8% | 0.02% | -28.0% |
| Q3 2013 | $274,000 | – | 3,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |